Publication | Open Access
Melanoma Therapy via Peptide-Targeted α-Radiation
133
Citations
27
References
2005
Year
Treatment of B16/F1 murine melanoma-bearing mice with (212)Pb[DOTA]-Re(Arg(11))CCMSH significantly decreased tumor growth rates resulting in extended mean survival times, and in many cases, complete remission of disease. (212)Pb-DOTA-Re(Arg(11))CCMSH seems to be a very promising radiopharmaceutical for targeted radionuclide therapy of melanoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1